Close

Not a member yet? Register now and get started.

lock and key

Sign in to your account.

Account Login

Forgot your password?

Healthcare  // Browsing posts in Healthcare

Reimbursement Key for EDAP & Profound to Challenge Standard of Care (EDAP, PROF)

Research Question: Will EDAP’s and Profound Medical’s minimally invasive prostate cancer treatments significantly challenge the standard of care of surgery and radiation? Companies: EDAP, PROF By: David Franklin Click here to download report (.pdf)   Summary of Findings High-intensity focused ultrasound (HIFU) for the treatment of prostate cancer will challenge the standard of care—radical prostatectomy […]

Read more...

Cardiovascular Systems & ShockWave Both Have Growth Opportunities (CSII, SWAV)

Research Question: Will Cardiovascular Systems extend its growth trend or will it be disrupted by ShockWave and other competitors? Companies: BSX,CSII, MDT, SWAV   By: David Franklin Click here to download report (.pdf)   Summary of Findings Both Cardiovascular Systems Inc. (CSII) and ShockWave Medical Inc. (SWAV) can extend their growth trends over the next […]

Read more...

Prostate Cancer Treatment Idea Proposal (EDAP, PROF)

Prostate Cancer Treatment Idea Proposal (EDAP, PROF)

Will EDAP’s and PROF’s minimally invasive prostate cancer treatments significantly challenge the standard of care of surgery and radiation? Report Available: March 25, 2021   Blueshift’s initial research found that high intensity focused ultrasound (HIFU), a prostate cancer treatment that uses the energy of highly focused ultrasound to pinpoint, heat, and kill prostate cancer cells, […]

Read more...

Cardiovascular Systems Idea Proposal (CSII)

Cardiovascular Systems Idea Proposal (CSII)

Will Cardiovascular Systems extend its growth trend, or will it be disrupted by ShockWave and other competitors? Report Available: March 10, 2021   Blueshift’s initial research found the coronary artery disease (CAD) and peripheral artery disease (PAD) treatment space poised for solid recovery as the coronavirus pandemic medical procedure moratorium begins to subside. Two device […]

Read more...

Alphatec and its CEO Generating High Interest Levels; Continued Growth Expected (ATEC)

Research Question: Can Alphatec’s product development program and strategic distributor sales channel initiatives deliver sustained double-digit growth? Companies: ATEC, GMED, JNJ, MDT, NUVA, SPNE, SYK, ZBH By: David Franklin Click here to download report (.pdf)   Summary of Findings Alphatec Holdings Inc.’s (ATEC) product development program and its sales channel changes generated mixed opinions regarding […]

Read more...

Alphatec Holdings Idea Proposal (ATEC)

Alphatec Holdings Idea Proposal (ATEC)

Can Alphatec’s product development program and strategic distributor sales channel initiatives deliver sustained double-digit growth? Report Available: January 7, 2021   Blueshift’s initial research found ATEC transformed by a new leadership team, shedding its past legacy of lacking distinction to one providing innovative spine surgery solutions. The company is now promoting clinical excellence by introducing […]

Read more...

Inspire Use Likely to Grow When COVID Subsides, Expansion Effort Pays Dividends (INSP)

Research Question: Can Inspire execute on its commercial expansion initiative to accelerate growth or is its implantable therapy a niche treatment? Companies: INSP, LIVN, NYXH By: David Franklin Click here to download report (.pdf)   Summary of Findings Inspire Medical Systems Inc.’s (INSP) minimally invasive hypoglossal nerve stimulation device for the treatment of moderate to […]

Read more...

Inspire Medical Systems Idea Proposal (INSP)

Inspire Medical Systems Idea Proposal (INSP)

Can Inspire execute on its commercial expansion initiative to accelerate growth or is its implantable therapy a niche treatment? Report Available: December 10, 2020   Blueshift’s initial research found INSP working to accelerate the use and adoption of its Inspire system for the treatment of obstructive sleep apnea (OSA). Direct-to-consumer advertising, increased physician outreach and […]

Read more...

Neuronetics Faces Significant Headwinds to Reinvigorate Growth (STIM)

Research Question: Will Neuronetics’ C-suite changes, new treatment indication, expanded reimbursement, and new positive data reinvigorate growth? Companies: BWAY, GTMS, NXTMH.HE, STIM By: David Franklin Click here to download report (.pdf)   Summary of Findings Neuronetics Inc.‘s (STIM) business model, requiring psychiatric practices and TMS (transcranial magnetic stimulation) clinics to spend significant sums to acquire […]

Read more...

Neuronetics Idea Proposal (STIM)

Neuronetics Idea Proposal (STIM)

Will Neuronetics’ C-suite changes, new treatment indication, expanded reimbursement, and new positive data reinvigorate growth? Report Available: November 4, 2020   Blueshift’s initial research found STIM, a leader in providing transcranial magnetic stimulation (TMS) therapy equipment and support for the treatment of Major Depressive Disorder (MDD), navigating through the coronavirus, which has had a significant […]

Read more...